The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $102.05

Today's change-1.37 -1.32%
Updated March 6 12:36 PM EST. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $102.05

Today's change-1.37 -1.32%
Updated March 6 12:36 PM EST. Delayed by at least 15 minutes.

Gilead Sciences Inc crosses below 125-day moving average

Gilead Sciences Inc is lower today, dropping (U.S.)$1.37 or 1.32% to (U.S.)$102.05 and crossing below its 125-day moving average. Shares have lost 1.43% over the last five days, but have gained 8.26% over the last year to date. This security has outperformed the S&P 500 by 17.04% during the last year.

Key company metrics

  • Open(U.S.) $103.00
  • Previous close(U.S.) $103.42
  • High(U.S.) $103.75
  • Low(U.S.) $101.93
  • Bid / Ask(U.S.) $102.03 / (U.S.) $102.05
  • YTD % change+8.26%
  • Volume4,293,944
  • Average volume (10-day)8,024,652
  • Average volume (1-month)12,937,229
  • Average volume (3-month)16,167,623
  • 52-week range(U.S.) $63.50 to (U.S.) $116.83
  • Beta0.78
  • Trailing P/E13.85×
  • P/E 1 year forward10.85×
  • Forward PEG0.78×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.37
Updated March 6 12:36 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+48.45%

Based on its net profit margin of 48.45%, Gilead Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.91%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue7,3146,0426,5354,999
Total other revenue--------
Total revenue7,3146,0426,5354,999
Gross profit6,2515,0555,6104,186
Total cost of revenue1,063987925813
Total operating expense2,9842,5632,1221,956
Selling / general / administrative876945614548
Research & development1,045630584595
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,3303,4794,4133,043
Interest income (expense), net non-operating-130-103-102-76
Gain (loss) on sale of assets--------
Other--------
Income before tax4,2303,3714,3072,948
Income after tax3,4622,7243,6502,223
Income tax, total768647657726
Net income3,4872,7313,6562,227
Total adjustments to net income--------
Net income before extra. items3,4872,7313,6562,227
Minority interest25755
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,4872,7313,6562,227
Inc. avail. to common incl. extra. items3,4872,7313,6562,227
Diluted net income3,4872,7313,6562,227
Dilution adjustment--------
Diluted weighted average shares1,6011,6371,6641,680
Diluted EPS excluding extraordinary itemsvalue per share2.181.672.201.33
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share2.181.672.201.33